コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 utaneous vaccine with respect to the rate of seropositivity.
2 rology, likely due to the high prevalence of seropositivity.
3 magnetic resonance imaging, correlated with seropositivity.
4 e also evaluated factors associated with HEV seropositivity.
5 s, only older age remained predictive of HEV seropositivity.
6 ost significant risk factors associated with seropositivity.
7 continues to challenge the interpretation of seropositivity.
8 xposure is independently associated with HPV seropositivity.
9 for human papillomavirus (HPV)-16 and HPV-18 seropositivity.
10 nce of H1N1pdm09 vaccination or pre-pandemic seropositivity.
11 were strongly associated with post-pandemic seropositivity.
12 fer significantly according to recipient CMV seropositivity.
13 recent seroconversion, as well as sustained seropositivity.
14 als) as witnessed by their hepatitis C virus seropositivity.
15 n in Brazil, both tests detected 28%(n = 17) seropositivity.
16 tients had titers considered at baseline for seropositivity.
17 (1.9%) and other species exhibiting </=0.6% seropositivity.
18 al pathogen-specific antibody was considered seropositivity.
19 cantly associated with increased odds of HEV seropositivity.
20 fetal immunoglobulin M (IgM) umbilical cord seropositivity.
21 alarials were associated with HCV subtype 4k seropositivity.
22 ause survival in relation to HPV16 E6 and E7 seropositivity.
23 nd individual characteristics that relate to seropositivity.
24 ated with increasing age and cytomegalovirus seropositivity.
25 ere associated with 16/18 and 31/33/45/52/58 seropositivity.
26 and B-cell proportions by BK, JC, and HPyV9 seropositivity.
27 ause survival in relation to HPV16 E6 and E7 seropositivity.
28 HBV genotype C infection and maternal HBsAg seropositivity.
29 = 1.7 x 10(-8)), to be associated with HPV77 seropositivity.
30 memory was exhibited by 45% on the basis of seropositivity 1 week after vaccination and by 29% on th
31 usion criteria were as follows: (1) AQP4-IgG seropositivity, (2) myelitis attack and (3) MRI spinal c
33 %-70%] vs 98% [95% CI, 95%-100%]), and mumps seropositivity (59% [95% CI, 55%-64%] vs 97% [95% CI, 94
34 ine response occurred in 46% on the basis of seropositivity 8 weeks after vaccination and in 37% on t
35 assay (ELISA) thresholds for HPV16 and HPV18 seropositivity (8 and 7 ELISA units/mL, respectively, fo
37 2.36) and inversely associated with SE36IgG1 seropositivity (adjusted OR: 0.37; 95% CI 0.21-0.64) and
38 BL was positively associated with HRP-IIIgG3 seropositivity (adjusted OR: 1.60; 95% CI 1.08-2.36) and
40 atitis A virus (anti-HAV) on the duration of seropositivity after hepatitis A vaccination during infa
44 B. pseudomallei from a soil sample and high seropositivity among patient contacts suggest at least r
46 ted an age-dependent association between HCV seropositivity and albuminuria (adjusted odds ratios and
47 al association between prevalent hepatitis C seropositivity and albuminuria and estimated GFR (eGFR),
48 a significantly higher risk of toxocariasis seropositivity and Anisakis simplex sensitization when c
49 prevalence of Toxocara spp. and Ascaris spp. seropositivity and associations with allergic diseases a
53 ically significant association between HSV-2 seropositivity and CD4 count over time, but this differe
55 ion that showed association between anti-HEV seropositivity and functional epsilon3 and epsilon4 alle
60 ant recipient cytomegalovirus (CMV) antibody seropositivity and lack of aggressive prophylaxis agains
61 ificant association observed for hepatitis C seropositivity and low eGFR (<60 ml/min per 1.73 m(2); a
62 ns in p53 degradation, we evaluated HPV16 L1 seropositivity and MDM2 promoter variants to examine the
64 ates the association between cytomegalovirus seropositivity and outcome in a large population of noni
66 was no significant association between HSV-2 seropositivity and the presence of fibroids (multivariab
69 ion less than 3 vertebral segments, AQP4-IgG seropositivity, and a final diagnosis of NMO or NMOSD.
70 C-reactive protein levels, rheumatoid factor seropositivity, and a lack of current treatment with dis
72 tuberculosis infection, hepatitis B and HIV seropositivity, and child and adult vaccination needs th
73 90 and were followed for analysis of safety, seropositivity, and neutralizing antibodies to DENV-1-4.
74 ptic neuritis, transverse myelitis, AQP4-IgG seropositivity, and recurrent myalgias with hyperCKemia.
75 hyroid peroxidase, and anti-transglutaminase seropositivity, and these autoantibodies did not correla
78 ransplant recipients that betapapillomavirus seropositivity around transplantation significantly incr
82 iable DRB locus within the MHC region to HPV seropositivity at both the individual HPV type level and
83 gated whether neuromyelitis optica (NMO) IgG seropositivity at the initial presentation of longitudin
84 sed by occupational flour exposure and wheat seropositivity based on cross-reactivity to grass pollen
85 f 225 children was evaluated for CMV and EBV seropositivity before 2 years of age and for vaccination
87 screening study of various NAbs showed 22.5% seropositivity belonging mostly to VGKC-complex antibodi
93 plantation and that cytomegalovirus antibody seropositivity correlated with increased negative remode
101 were significantly associated with TES-ELISA seropositivity except vitreits (X(2) = 8.557, p = 0.003)
103 nfluenza A(H7N9) infection in China found no seropositivity for antibodies specific for avian-origin
104 c groups, the number (weighted frequency) of seropositivity for antibody to HAV was 958 (24.9%), 802
110 for at least 1 of the 6 HY-Abs, and 3-month seropositivity for each HY-Ab was associated with a pers
114 l associations were observed between BCC and seropositivity for HPV types in genus-alpha (odds ratio
118 itis in patients with RA was associated with seropositivity for RF and the anti-CCP antibody, which w
119 ubset of patients studied for all endpoints, seropositivity for the E6 and E7 proteins was significan
120 (odds ratio, 12.3; 95% CI, 5.4 to 26.4), and seropositivity for the HPV-16 L1 capsid protein (odds ra
122 roup, antirotavirus immunoglobulin A and IgG seropositivity frequencies before vaccination (52.7% and
124 ore, patients with p16 staining and E6 or E7 seropositivity had favorable survival from oropharyngeal
126 year among those with donor or recipient CMV seropositivity (hazard ratio 2.0: 95% confidence interva
127 mortality included recipient cytomegalovirus seropositivity (HR 1.40, 95% CI 1.13-1.74, p=0.0020), re
128 % CI 1.1 to 1.2; P = 0.004), and hepatitis C seropositivity (HR 2.8; 95% CI 1.1 to 7.0; P = 0.03) wer
133 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic blacks or between any sin
134 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic whites or Mexican America
137 ce of immunoblot-confirmed B burgdorferi IgG seropositivity in our uveitis patients is only slightly
138 over years, and prolonged waxing and waning seropositivity in some subjects, raises the possibility
144 strata, and analyzed factors associated with seropositivity, including age, gravidity, human immunode
146 respectively), whereas donor cytomegalovirus seropositivity increased the risk for late-onset IA (ie,
148 antibody to HEV (anti-HEV) immunoglobulin G seropositivity indicating past or recent HEV infection a
151 omarker of Epstein-Barr virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking s
152 immunodeficiency virus (HIV) and hepatitis B seropositivity, intestinal parasite test positivity, nee
155 eroprevalence rate of 36%, we find that HCMV seropositivity is associated with lower NK cell IFN-gamm
158 ssociation noted between rs41270488 and HPV8 seropositivity is driven by two independent variants, na
161 at the risk of OSCC associated with HPV16 L1 seropositivity is modified by MDM2 promoter polymorphism
165 We conclude that donor and/or recipient CMV seropositivity is still associated with an adverse progn
167 minants of seropositivity at age 4 were cord seropositivity (JCPyV, HPyV7, HPyV10, CMV), vaginal deli
168 born during 1967-1976 had the lowest measles seropositivity levels and represent populations that mig
169 population subgroups had evidence of measles seropositivity levels greater than the estimated thresho
170 galovirus (CMV)-specific cells, although CMV seropositivity modulated the distribution of lymphocyte
172 h was significantly different from the 53.6% seropositivity observed in the overall MS study populati
173 icient 0.54; p<0.0001) and increased odds of seropositivity (odds ratio 1.59 [95% CI 1.1-2.3]) adjust
174 ntly associated with a CD4/CD8 ratio <1: CMV seropositivity (odds ratio [OR], 1.9 [95% confidence int
175 s, 19.5% (22 of 113) for blood samples, with seropositivity of 62.8% (71 of 113 samples) and with inc
177 s with chronic urticaria more frequently had seropositivity of fasciolosis, Anisakis simplex sensitiz
180 from a CMV-seronegative donor, cases of CMV seropositivity of the donor and/or the recipient showed
181 The authors estimated the effect of HSV-2 seropositivity on HIV RNA viral load and on CD4 count ov
182 inically meaningful effect of baseline HSV-2 seropositivity on the trajectories of HIV plasma viral l
183 s found no associations between maternal IgG seropositivity or antibody levels to herpes simplex viru
184 determine the association between cord serum seropositivity or detectable C-reactive protein and NICU
185 We found no associations between H. pylori seropositivity overall either by whole-cell ELISA test o
188 ic CD8(+) T-cell analysis (P = .05), and CMV seropositivity (P = .01) were associated with a higher p
190 otypes of the two polymorphisms and HPV16 L1 seropositivity (P(int) = 0.060 for MDM2-rs2279744, P(int
191 flammatory markers, disease activity scores, seropositivity, physical disability, destructive changes
192 95% confidence interval, 1.30-23.62), as did seropositivity (positive likelihood ratio, 3.69 [1.67-8.
198 nfection in fathers, relative to the average seropositivity rate of 9.8% for boys and men aged 12-49
206 imary endpoint were GMCs and expected infant seropositivity rates, defined by birth anti-PT >30 enzym
208 Recurrent hyperCKemia accompanying AQP4-IgG seropositivity reflects targeting of skeletal muscle AQP
210 efined by infant hepatitis B surface antigen seropositivity (risk ratio = 0.3, 95% confidence interva
211 nfidence interval 0.2-0.4) or infant HBV DNA seropositivity (risk ratio = 0.3, 95% confidence interva
212 netheless, the model indicated that anti-HAV seropositivity should persist for >/=30 years after vacc
214 resulted in outer surface protein A-specific seropositivity that led to reductions of 23% and 76% in
215 those with both the TT genotype and HPV16 L1 seropositivity, the associated OR was 5.57 (95% CI, 2.93
216 childhood available for sampling maintained seropositivity through age 15-16 years; however, seropos
217 g/fall waves of the pandemic for evidence of seropositivity (titer >/=40) using the hemagglutination
219 We used a multiplex panel to assess whether seropositivity to 15 Helicobacter pylori proteins was as
220 herefore investigated whether preexisting Ad seropositivity to 7 different Ad serotypes was associate
222 owever, 69%-74% of children maintained their seropositivity to AMA1 alleles and 42%-52% to MSP2 allel
224 associations with gastric adenocarcinoma and seropositivity to different Helicobacter pylori antigens
228 stitution (N145K/R) was sufficient to affect seropositivity to H3N2v viruses in some individuals.
229 of HIV-infected patients exhibit persistent seropositivity to HIV-1 and evidence of immune activatio
230 imens for HPV DNA or included assessments of seropositivity to HPV type 6, 11, 16, or 18 in men.
233 sorbent assay (ELISA) (HPV16 and HPV18 only) seropositivity to measures of HPV exposure, HPV DNA posi
235 the Step study, we observed that preexisting seropositivity to multiple Ad serotypes was not intrinsi
237 onclusions, our cross-sectional study showed seropositivity to the NT5c1A antibody is associated with
239 ip between total infectious burden (additive seropositivity to various microbes) and cognition/AD.
254 fspring than parents; however, Toxocara spp. seropositivity was associated with increased risk of all
258 seropositive but MCV-seronegative, and HPyV7 seropositivity was associated with prolonged glucocortic
260 and crypt depth measurements showed that HEV seropositivity was associated with worse enteropathy (P
262 e screened by recombinant ELISA and MERS-CoV seropositivity was confirmed by recombinant immunofluore
266 oped hepatobiliary cancer, the prevalence of seropositivity was higher: 100% for gallbladder cancer,
271 positivity through age 15-16 years; however, seropositivity was less frequent among those starting va
277 on Into Cancer and Nutrition study, HPV16 E6 seropositivity was present more than 10 years before oro
284 tigate factors associated with cutaneous HPV seropositivity, we conducted a cross-sectional study of
285 V infection, and herpes simplex virus type 2 seropositivity were also predictive of incident HIV infe
286 -2.19] for OSCC risk, and GT/GG and HPV16 L1 seropositivity were associated with an OR of 2.81 (95% C
287 rus (CMV) and herpes simplex virus 1 (HSV-1) seropositivity were associated with cognitive impairment
288 Among middle-aged adults, HSV-1 and CMV seropositivity were associated with impaired coding spee
289 hic and lifestyle factors with cutaneous HPV seropositivity were estimated using odds ratios and 95%
291 rted between 12 and 24 weeks of age, odds of seropositivity were increased 13.7 times (95% CI 3.1-60.
292 ariate analyses, factors associated with HEV seropositivity were increasing age (P-trend<0.001), birt
293 Independent risk factors for HCV subtype 4r seropositivity were intramuscular tuberculosis therapy,
297 onversion within 1 year (n=45), new anti-HCV seropositivity with clinical acute hepatitis (n=21), or
299 a susceptibility locus (rs41270488) for HPV8 seropositivity within the major histocompatibility compl
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。